Jessica J. Federer
Board member & Former Chief Digital Officer of Bayer A.G.
Jessica Federer is a board member and former big pharma executive adept at deploying technology to make meaningful advancements for both business and society.
Her experience includes serving on public boards in the US and Canada, and private boards in the US, Germany, Switzerland and Italy.
Previously, she was one of the first Chief Digital Officers for the life sciences industry, leading the global digital transformation for Bayer A.G. across the Pharmaceutical, Consumer Care, Crop Science and Animal Health businesses.
She has advised both Fortune Global 100 companies and industry disrupting start-ups.
During the pandemic, she joined Europe’s fastest growing digital health company, Huma, as Managing Director / US CEO, establishing a U.S. team and expanding into decentralized clinical trials for international Covid-19 vaccine studies.
Jessica is recognized as a 2023 “Icon” by Rock Health, a Health Equity leader, and one of the top 100 CDOs.
She serves on the Yale Ventures Blavatnik board and the Yale IRB, and previously was on the United Nations ITU advisory board, and the BHP Technology Advisory Board.
Federer began her public health career as an analyst at the Agency for Healthcare Research and Quality in the US Department of Health and Human Services. She earned a Bachelor of Science from the George Washington University, and a Master of Public Health from Yale.
Meet our other board members:
